Steven Reynolds1, Tooba Alizadeh2, Becky Bibby2, Matthew Fisher2, Adriana Bucur1, Samira Kazan2, Martyn Paley1, Gillian M. Tozer2
1Academic Radiology, University of Sheffield, Sheffield, South Yorkshire, United Kingdom; 2Department of Oncology, University of Sheffield, Sheffield, South Yorkshire, United Kingdom
There has been recent interest in using hyperpolarised 13C1-pyruvate for studying cancer metabolism. The methodology has been used to study the effect of dichloroacetate (DCA) on tumour metabolism which disrupts pyruvate dehydrogenase kinase (PDK). However, these studies have been acute treatments up to 24h. In this study we examine the effect of chronic oral DCA dosing on P22 bearing BDIX rats over 17 days. The data showed a strong negative linear correlation between conversion of pyruvate to lactate and tumour volume and that there was a significant difference in the slope of the correlation between control and DCA treated rats.